In type 1 diabetes, the body can’t make its own ... For example, 35 units in the morning and 10 units at night mean you need a 0.3-mL syringe and a 0.5-mL syringe for each dose.

Biocon Biologics' biosimilar Yesintek is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis ...

National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of 0.5ML Autodisable Syringes manufactured by Afrimedical Manufacturing and Supplies Limited, Ibafo, Ogun ...

The global intradermal injection market size is expected to surpass an impressive valuation of USD 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

Thus the 1.0 mL label contributes to Patient Blood Management. The safePICO blood gas syringe is already barcoded, helping you match the sample with the correct patient. With the FLEXLINK data ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

When purifying proteins and other actives in production or research environments the aim is to achieve the purest possible ...

In fact, each Revok50 syringe contains 50 mg of HA with a molecular weight of ... and larger aliquots of about 0.1 mL per ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.